Skip to content

Study of quality of life after completion of Re-Radiation treatment in Head and Neck Cancer patients

Quality of life and swallowing outcomes after re-irradiation for recurrent and second primary head and neck cancers.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012370
Enrollment
200
Registered
2018-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients receiving re-Irradiation (reRT).

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients must have recurrence/ second primary (SPN) at least 6 months after prior radiotherapy. 2. Patients should have histopathological proof for both the primary tumor and at recurrence / second cancer in the head and neck region. 3. Patients should have been treated with radical intent for primary tumor with appropriate radical doses of radiation. 4. Patients who are diagnosed with recurrent or second cancer for which the radiation portals will overlap the fields of previously irradiated region. 5. In the recurrent setting the intention of treatment is radical.

Exclusion criteria

Exclusion criteria: 1.Patients having recurrence/ second primary (SPN) before completion of 6 months of prior radiotherapy. 2. Patients being treated with palliative intent in recurrent setting. 3. Radiation portals not overlapping the fields of previously irradiated region.

Design outcomes

Primary

MeasureTime frame
To document and evaluate change in quality of Life in patients receiving reRT for recurrence or second primary.Timepoint: After Completion of Radiation therapy

Secondary

MeasureTime frame
1.To evaluate changes in swallowing function, in patients receiving reRT. 2.To establish dosimetric relationship between Dysphagia Aspiration Related Structures and severity of swallowing dysfunction in patients receiving Re-RT. 3.To determine Incidence rate of acute and late toxicities associated with reRT. 4.To determine DFS/ local control rates/ OS rates from date of diagnosis of second primary/ recurrence. 5. To determine the pattern of disease progression post treatment in all patients.Timepoint: After Completion of Radiation therapy

Countries

India

Contacts

Public ContactDr Carlton Johnny

Tata Memorial Hospital

sarbanilaskar@gmail.com9820834386

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026